CSS
VBIV

Cubist Systematic Strategies’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Cubist Systematic Strategies’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-216
Closed -$2.53K – 4581
2022
Q4 		$2.53K Buy
216
+213
+7,100% +$3.76K ﹤0.01% 4116
2022
Q3 		$0 Sell
3
-224
-99% -$6.04K ﹤0.01% 4836
2022
Q2 		$6K Sell
227
-123
-35% -$4.19K ﹤0.01% 4292
2022
Q1 		$17K Buy
350
+347
+11,567% +$17.1K ﹤0.01% 3484
2021
Q4 		$0 Sell
3
-474
-99% -$39.9K ﹤0.01% 3686
2021
Q3 		$45K Buy
+477
New +$45.3K ﹤0.01% 2846
2021
Q2 		– Sell
-1,470
Closed -$137K – 3147
2021
Q1 		$137K Buy
+1,470
New +$149K ﹤0.01% 2587
2020
Q3 		– Sell
-444
Closed -$41K – 2682
2020
Q2 		$41K Buy
+444
New +$24.5K ﹤0.01% 2282

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return